BB-39-DQ95_1uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=1uM, 5-methyl-3,6-diphenylisoxazolo[4,5-c]pyridin-4(5H)-one, mgluR7 Antagonists targeting GRM7 (Novartis, 4250909)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/4250909
Similar Terms
Downloads & Tools

Genes

12 genes differentially expressed following the BB-39-DQ95_1uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
MYL6 myosin, light chain 6, alkali, smooth muscle and non-muscle 1.40186
MYL2 myosin, light chain 2, regulatory, cardiac, slow 0.94744
MRPL52 mitochondrial ribosomal protein L52 0.660222
RPL37 ribosomal protein L37 0.465204
RPS16 ribosomal protein S16 0.428584
MTHFD1 methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1, methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthetase 0.326157
DAD1 defender against cell death 1 0.215779

decreased expression

Symbol Name Standardized Value
TAF1D TATA box binding protein (TBP)-associated factor, RNA polymerase I, D, 41kDa -0.46357
ABL2 ABL proto-oncogene 2, non-receptor tyrosine kinase -0.305056
CHML choroideremia-like (Rab escort protein 2) -0.305056
FAM177A1 family with sequence similarity 177, member A1 -0.225069
PRIM2 primase, DNA, polypeptide 2 (58kDa) -0.212188